SEHK:2157Biotechs
Assessing Lepu Biopharma (SEHK:2157) Valuation After Its Earnings Turnaround And Recent Share Price Strength
Lepu Biopharma (SEHK:2157) just reported full year 2025 earnings, with sales of CN¥934.87 million and net income of CN¥261.36 million, compared with a net loss a year earlier.
See our latest analysis for Lepu Biopharma.
The earnings swing appears to be feeding into sentiment, with the HK$5.6 share price sitting after an 8.74% 1 day share price return, a 22.81% 30 day share price return and a 46.98% 1 year total shareholder return. This suggests that momentum has been building recently.
If...